Literature DB >> 21130393

The safety and interpretability of skin tests with omalizumab.

Phillip Lieberman, Abdelkader Rahmaoui, Dennis A Wong.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21130393     DOI： 10.1016/j.anai.2010.10.008

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  4 in total

Review 1.  Hypersensitivity Reactions to Biologicals: from Bench to Bedside.

Authors:  Aysegul Akarsu; Ozge Soyer; Bulent Enis Sekerel
Journal:  Curr Treat Options Allergy       Date:  2020-01-18

2.  Effects of omalizumab therapy on peripheral nerve functions: short observational study.

Authors:  Goknur Ozaydın Yavuz; Abdullah Yılgör; Ibrahim Halil Yavuz; Aysel Milanlıoğlu; Vedat Çilingir; Aydın Çağaç; Murat Ozturk; Serap Gunes Bilgili
Journal:  Postepy Dermatol Alergol       Date:  2018-04-03       Impact factor: 1.837

Review 3.  Hypersensitivity and Immune-related Adverse Events in Biologic Therapy.

Authors:  Jamie L Waldron; Stephen A Schworer; Mildred Kwan
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-28       Impact factor: 8.667

Review 4.  Immunomodulators in chronic rhinosinusitis.

Authors:  Philippe Lavigne; Stella E Lee
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2018-11-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.